Analysts at StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research report issued on Monday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens lifted their price target on Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Friday, January 31st.
Check Out Our Latest Stock Analysis on MDRX
Veradigm Stock Up 0.6 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- Canada Bond Market Holiday: How to Invest and Trade
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Must-Own Stocks to Build Wealth This Decade
- How to trade using analyst ratings
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
